If you find value in this type of content, we invite you to connect with us!

Click here to join our Discord:  Real Peptide Talk
Visit our blog:   https://peptideresearch.us
Join our Newsletter list:  https://peptideresearch.us/newsletter
Follow us on Facebook

In this episode of the NRG BioLabs Peptide Research Podcast, we clear up the confusion surrounding GLP-1, GLP-2 and the newer GLP-3 type compounds. The goal is to make metabolic science simple enough for any listener to understand while still giving researchers and educated learners meaningful insight.

We walk through how the body uses GLP messengers to communicate with the brain, pancreas and digestive system. Listeners will learn how GLP-1 influences appetite and blood sugar, how GLP-2 supports the gut, and why scientists are studying triple agonist compounds that activate three pathways at the same time.

We also explain where well known compounds fit into the picture. Semaglutide works through the GLP-1 pathway, Tirzepatide works through both GLP-1 and GIP, and Retatrutide is being studied for activity in three different metabolic systems at once. Each category works in a unique way, and we make those differences clear with easy examples and simple language.

The episode also clarifies the important difference between research peptides and prescription medications so listeners understand what belongs in controlled laboratory settings.

This conversation is helpful for anyone who wants a clear explanation of how these metabolic messengers work and why research interest in them continues to grow.

To read the corresponding article, go to: https://peptideresearch.us/what-is-the-difference-between-glp-1-glp-2-and-glp-3/